This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University of California, Carlos Antonio Tindade Da Silva. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2023
Title: Fawaz G Haj: Innovator in Bone Health and Pain Management
Introduction
Fawaz G Haj is a notable inventor based in Davis, CA (US). He has made significant contributions to the fields of bone health and pain management through his innovative patents. With a total of 2 patents, his work focuses on addressing critical health issues.
Latest Patents
Fawaz G Haj's latest patents include methods for treating bone loss. These patents provide compositions and methods for preventing, mitigating, decreasing, inhibiting, and/or reversing bone loss. They also aim to increase and promote bone regeneration and remodeling, as well as prevent, mitigate, decrease, inhibit, and/or reverse periodontitis and periodontal disease. This is achieved by administering an effective amount of an inhibitor of soluble epoxide hydrolase (sEH) to the subject. Additionally, he has developed methods for inhibiting pain, particularly neuropathic pain. These methods involve the combined administration of an agent that increases EETs and an agent that reduces or inhibits endoplasmic reticulum (ER) stress.
Career Highlights
Fawaz G Haj has worked with esteemed institutions, including the University of California. His research and innovations have contributed to advancements in medical treatments and therapies.
Collaborations
Some of his notable coworkers include Ahmed Bettaieb and Ahmet Bora Inceoglu. Their collaborative efforts have further enhanced the impact of his inventions.
Conclusion
Fawaz G Haj's contributions to the fields of bone health and pain management through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the medical community and offers hope for effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile